Clinical Trial Update: Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial of peritransplant deoxyspergualin in islet transplantation for Type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Deoxyspergualin (deoxyspergualin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED